Anti-Psychotics

Not just a nursing home problem: Antipsychotic use increasing in elderly, community-dwelling dementia patients

Not just a nursing home problem: Antipsychotic use increasing in elderly, community-dwelling dementia patients

By

While regulatory focus has pushed the use of antipsychotics lower in skilled nursing facilities recently, off-label use is rising among dementia patients living in assisted living and other community settings.

60 seconds with Daniel Cannone, D.O., United Church Homes

60 seconds with Daniel Cannone, D.O., United Church Homes

Q: The United Church Homes has reduced antipsychotic medications dramatically since 2012. How did you accomplish that?

FDA approves antipsychotic that includes tracking sensor

FDA approves antipsychotic that includes tracking sensor

By

The Food and Drug Administration approved a new type of antipsychotic pill in November that is able to share information about when it was taken with patients and providers — but the new tech comes with a warning for older patients.

Nursing homes no longer subject to independent pharmacist regulation

Nursing homes no longer subject to independent pharmacist regulation

By

Federal regulators have reversed a controversial proposal that would have required facilities to hire consultant pharmacists to review residents' medications.

CMS announces expansion of psychiatric services for seniors

CMS announces expansion of psychiatric services for seniors

By

The Centers for Medicare & Medicaid Services is launching two new initiatives that may improve mental health services for seniors and nursing home residents.

Massachusetts looks for alternatives to antipsychotic use in dementia residents

Nursing home regulators in Massachusetts Thursday launched a campaign to limit the use of antipsychotic drugs in facilities.